Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

European Journal of Pharmacology: Molecular Pharmacology

Volumn 225, Issue 4, 1992, Pages 331-337

  Sokoloff, Pierre ^a   Andrieux, Marc ^a   Besançon, Roger ^a   Pilon, Catherine ^a   Martres, Marie Pascale ^a   Giros, Bruno ^a   Schwartz, Jean Charles ^a  

^a CENTRE PAUL BROCA   (France)

Author keywords

Dopamine autoreceptor; Dopamine D3 receptor (human); Eukaryotic expression vector; G protein; Guanylnucleotide; Neuroleptics; Transfected cell

Indexed keywords

2 DIMETHYLAMINO 6,7 DIHYDROXYTETRALIN; 2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; AMISULPRIDE; APOMORPHINE; CARPIPRAMINE; CHLORPROMAZINE; CLOZAPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLYLIMIDODIPHOSPHATE; HALOPERIDOL; METOCLOPRAMIDE; MEZILAMINE; NEUROLEPTIC AGENT; PERGOLIDE; PIMOZIDE; PIPOTIAZINE; PROCHLORPERAZINE; QUINELORANE; QUINPIROLE; RADIOLIGAND; REMOXIPRIDE; SULPIRIDE; SULTOPRIDE; THIOPROPERAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CHO CELL; CONTROLLED STUDY; DRUG CONCENTRATION; GENETIC TRANSFECTION; HUMAN; MEMBRANE BINDING; MOLECULAR CLONING; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ANIMAL; CHLORIDES; CHO CELLS; COMPARATIVE STUDY; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; GUANYLYL IMIDODIPHOSPHATE; HAMSTERS; HUMAN; LITHIUM; LITHIUM CHLORIDE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; SODIUM CHLORIDE; SULPIRIDE; TRANSFECTION;

EID: 0026604248     PISSN: 09224106     EISSN: None     Source Type: Journal    
DOI: 10.1016/0922-4106(92)90107-7     Document Type: Article

References (35)

1. 2 receptor mRNA
2. 2 dopamine receptor cDNA
3. +-independent ligands
4. 2 receptor: two molecular forms generated by alternative splicing
5. 1 dopamine receptor
6. 2 dopamine receptor isoforms
7. 3 receptor and chromosome identification
8. 2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide
9. Substituted benzamide drugs as selective neuroleptics
10. Multiple receptors for dopamine
11. Amplification of genes. Amplification using dihydrofolate reductase
12. 3 dopamine receptor gene
13. 2-adrenergic receptor in membrane and solubilized pr preparations
14. Protein measurement with the Folin phenol reagent
15. A pharmacological comparison of 6,7 dihydroxy-2 dimethylaminotetralin (TL 99) and N-n-propyl-3(3-hydroxyphenyl) piperidine (3-PPP) with selected dopamine agonists
16. Selection of dopamine antagonists discriminating various behavioral responses and radioligand binding sites
17. 2 dopamine receptors produced by alternative RNA splicing
18. 1 dopamine receptor linked to adenylyl cyclase activation
19. 2 receptor cDNA expressed in a mammalian cell line
20. 2 receptor affinity for drugs and inhibition of adenylyl cyclase
21. Mapping of ß-adrenoceptor coupling domains to Gs-protein by site-specific synthetic peptides
22. Opiate receptor binding of agonists and antagonists affected differentially by sodium
23. Biochemical and behavioral identification of discriminant benzamide derivatives: new tools to differentiate subclasses of dopamine receptors
24. 3) as a target for neuroleptics
25. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system
26. Sodium-dependent interaction of benzamides with dopamine receptors
27. Identification of residues required for ligand binding to the ß-adrenergic receptor
28. Conserved aspartic acid residues 79 and 113 of the ß-adrenergic receptor have different roles in receptor function
29. 1 receptor encoded by an intronless gene on chromosome 5
30. 1
31. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists
32. Schizophrenic symptoms improve with apomorphine
33. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity
34. 4 receptor with high affinity for the antipsychotic clozapine
35. 1 dopamine receptors